Slide 1DEVELOPMENT OF EFFECTIVE ANTIVIRAL AGENTS OF A NEW TYPE Professor Oleg Shadyro Belarusian State University Department of Chemistry, Minsk, Belarus [email protected]…

Slide 1Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal…

Influenza Influenza Influenza is an acute systemic viral infection that primarily affects the respiratory tract it carries a significant mortality. It is caused by influenza…

Slide 1Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins Slide 2 Copyright © 2008 Lippincott Williams &…

Slide 1 Risk of acquired drug resistance during DOTS tuberculosis treatment in a setting of high drug resistance Helen S. Cox 1,3, Stefan Niemann 2, Gabit Ismailov 3, Daribay…

Slide 1 (classical) genetics causality phenotype DNA ‘reverse’ genetics Slide 2 Slide 3 Slide 4 Slide 5 T C Slide 6 Slide 7 Slide 8 Slide 9 Slide 10 Slide 11 Slide 12…

Slide 1 1 ANTI PROTOZOAL DRUGS Slide 2 INTRODUCTION They are eukaryotes and have metabolic processes closer to those of human host. Protozoal infections are common among…

Slide 1 Antibiotic Resistance and Medicinal Drug Policy Dr. Ken Harvey Dr. Ken Harvey School of Public Health, La Trobe University, Melbourne, Australia 1 Slide 2 2 Lecture…

Slide 1  1. Why can bacteria evolve just like we can?  2. Why do bacteria become antibiotic resistant?  3. In a population, 14% of the population should the dominant…

Slide 1 Microbiology: A Clinical Approach © Garland Science Slide 2  The most important problem associated with infectious disease today is the rapid development of resistance…